Sengenics is a company that develops and provides immunoproteomics technologies and services for biomarker discovery. The company markets two products, i-Ome Cancer and i-Ome Discovery, which are protein microarrays that allow customers to profile autoantibodies against a large number of protein antigens. Sengenics' technology is based on a patented KREX® protein folding technology that ensures that the proteins on the microarrays are correctly folded, increasing the accuracy and reproducibility of the results. Sengenics is also a certified Service Provider for Asia through their partnership with SML Meditree.

Sengenics

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 23, 2024 10:04 PM	da3b1fd1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 24, 2024 5:09 AM	38e92dcd
company summary	general
signals	general	Sep 23, 2024 10:04 PM	f8239db2
crunchbase trigger	general	Nov 27, 2024 12:50 PM	4507fa9a
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general	Sep 23, 2024 10:04 PM	7dc67c16
news basic	general	Sep 23, 2024 10:04 PM	ca0dc0d6
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SENGENICS

Sengenics